Advertisement
A new risk score incorporates readily accessible risk factors associated with the occurrence of stroke in patients after myocardial infarction in the absence of atrial fibrillation

New Risk Score Assesses Stroke Risk After MI Without A-Fib

0
Model includes age, Killip class, hypertension history to estimate risk in those without atrial fibrillation
There is a correlation for increased risk of amyotrophic lateral sclerosis with increased occupational exposures to diesel exhaust

AAN: Occupational Exposure to Diesel Exhaust Tied to ALS Risk

0
Increased odds of ALS for men in the highest quartile of exposure for five- and 10-year lag periods
For adults in Taiwan

Lifetime Risk for Atrial Fibrillation Is One in Seven in Taiwan

0
Among Asian patients, a-fib linked to increased risk of mortality, heart failure, ischemic stroke, dementia
For patients with gluten neuropathy

AAN: Gluten-Free Diet May Help Cut Pain in Gluten Neuropathy

0
Reduced odds of peripheral neuropathic pain for patients following strict gluten-free diet
8-oxo-7

Urinary 8-oxoGsn Promising Biomarker for Physiologic Age

0
In both genders, age-dependent increases in levels of 8-oxodGsn and 8-oxoGsn from age 21-30 to 81-90
Coronary artery bypass grafting is associated with a significant reduction in major adverse cardiac and cerebrovascular events and mortality compared with percutaneous coronary intervention among patients with diabetes mellitus

CABG May Be Best for Patients With DM, LV Dysfunction

0
Fewer adverse cardiac, cerebrovascular events, deaths with cardiac artery bypass graft than PCI
A low risk of serotonin syndrome is seen in association with concomitant use of triptans and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants

Low Risk of Serotonin Syndrome for Triptans + SSRI/SNRI

0
Researchers question FDA advisory warning on risk of concomitant use
Trials to evaluate drugs or devices used to treat chronic medical conditions that are published early in the chain of evidence often show an exaggerated treatment effect compared with subsequent trials

Early Studies Often Show Exaggerated Treatment Effect

0
Findings based on assessment of trials evaluating drugs, devices to treat chronic medical conditions
The prevalence of amyotrophic lateral sclerosis was 5.0 per 100

Prevalence of ALS Remained at 5.0/100,000 in U.S. in 2014

0
No change in prevalence of ALS from 2013; lowest prevalence for those aged 18 to 39 years
In a position paper published online Feb. 27 in the Annals of Internal Medicine

Recommendations for Optimizing Hidden Curriculum in Medicine

0
Clinical learning environment should be optimized by ensuring what is taught in classroom is modeled